Premium
Sirolimus for patients with progressive epithelioid hemangioendothelioma
Author(s) -
Smrke Alannah M.,
Huang Paul H.,
Jones Robin L.
Publication year - 2021
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.33246
Subject(s) - medicine , epithelioid hemangioendothelioma , sirolimus , epithelioid sarcoma , hemangioendothelioma , retrospective cohort study , soft tissue , pathology , radiology , surgery , immunohistochemistry
Epithelioid hemangioendothelioma is an ultrarare soft tissue sarcoma with limited literature to guide treatment. The results from a robust retrospective cohort study support the use of sirolimus for patients who have multifocal epithelioid hemangioendothelioma without serosal effusion.